Literature DB >> 2311862

Improvement in chronic hepatocerebral degeneration following liver transplantation.

E E Powell1, M P Pender, J B Chalk, P J Parkin, R Strong, S Lynch, P Kerlin, W G Cooksley, W Cheng, L W Powell.   

Abstract

Chronic progressive hepatocerebral degeneration with spastic paraparesis, dementia, dysarthria, ataxia, tremor, and neuropsychiatric symptoms follows long-standing portal-systemic shunting, is associated with structural changes in the central nervous system, and does not respond to conventional therapy for hepatic encephalopathy. A case of advanced chronic liver disease with severe, progressive hepatocerebral degeneration after 23 yr of portal-systemic shunting is reported in whom there was significant objective improvement in intellectual function and in the chronic neurological signs 3 mo after orthotopic liver transplantation and further improvement 12 mo after transplantation.

Entities:  

Mesh:

Year:  1990        PMID: 2311862     DOI: 10.1016/0016-5085(90)90036-z

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  14 in total

1.  Improvement in cognitive functioning of alcoholics following orthotopic liver transplantation.

Authors:  A M Arria; R E Tarter; T E Starzl; D H Van Thiel
Journal:  Alcohol Clin Exp Res       Date:  1991-12       Impact factor: 3.455

Review 2.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

Review 3.  Reversibility of hepatic encephalopathy after liver transplantation.

Authors:  Dileep K Atluri; Mehrdad Asgeri; Kevin D Mullen
Journal:  Metab Brain Dis       Date:  2010-03-05       Impact factor: 3.584

Review 4.  Altered modulation of motor activity by group I metabotropic glutamate receptors in the nucleus accumbens in hyperammonemic rats.

Authors:  Omar Cauli; Marta Llansola; Regina Rodrigo; Nisrin El Mlili; Mohammed Errami; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

5.  Chronic acquired hepatocerebral degeneration: effects of liver transplantation on neurological manifestations.

Authors:  A Stracciari; E Baldin; L Cretella; L Delaj; R D'Alessandro; M Guarino
Journal:  Neurol Sci       Date:  2011-02-17       Impact factor: 3.307

Review 6.  Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.

Authors:  J S Bajaj; J Cordoba; K D Mullen; P Amodio; D L Shawcross; R F Butterworth; M Y Morgan
Journal:  Aliment Pharmacol Ther       Date:  2011-02-09       Impact factor: 8.171

7.  Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients.

Authors:  Elisa Maffeo; Anna Montuschi; Guido Stura; Maria Teresa Giordana
Journal:  Neurol Sci       Date:  2013-05-28       Impact factor: 3.307

8.  Chronic acquired hepatocerebral degeneration presenting with Meige's syndrome and behavioral symptoms fully reversed by liver transplantation.

Authors:  Andrea Stracciari; Luca Spinardi; Maria Guarino
Journal:  Neurol Sci       Date:  2021-07-19       Impact factor: 3.307

Review 9.  Parkinsonism in cirrhosis: pathogenesis and current therapeutic options.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2012-10-20       Impact factor: 3.584

10.  Acquired hepatocerebral degeneration.

Authors:  Pushpendra Nath Renjen; Laxmi Khanna; Ruchi Rastogi; Nadeem Israr Khan
Journal:  BMJ Case Rep       Date:  2013-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.